Oversea-Chinese Banking Corporation Limited
Oversea-Chinese Banking Corporation Limited (OVCHY) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Oversea-Chinese Banking Corporation Limited (OVCHY), covering cash flow, earnings, and balance sheets.
Oversea-Chinese Banking Corporation Limited (OVCHY) Income Statement & Financial Overview
Analyze Oversea-Chinese Banking Corporation Limited’s OVCHY earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $3.65B | $17.17B | $3.80B | $9.99B |
| Cost of Revenue | $0.00 | $7.02B | $0.00 | $6.36B |
| Gross Profit | $3.65B | $10.15B | $3.80B | $3.63B |
| Gross Profit Ratio | $1.00 | $0.59 | $1.00 | $0.36 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $3.84B | $0.00 | $0.00 |
| Operating Expenses | $1.36B | $4.37B | $1.46B | $1.37B |
| Total Costs & Expenses | $1.36B | $11.38B | $1.46B | $7.74B |
| Interest Income | $2.35B | $13.65B | $2.43B | $8.79B |
| Interest Expense | $0.00 | $6.33B | $0.00 | $6.36B |
| Depreciation & Amortization | $5.00M | $310.00M | $7.00M | $212.00M |
| EBITDA | $2.30B | $13.28B | $2.42B | $8.91B |
| EBITDA Ratio | $0.63 | $0.77 | $0.64 | $0.89 |
| Operating Income | $2.30B | $5.79B | $2.34B | $2.26B |
| Operating Income Ratio | $0.63 | $0.34 | $0.62 | $0.23 |
| Other Income/Expenses (Net) | $0.00 | $858.00M | $75.00M | $77.00M |
| Income Before Tax | $2.30B | $6.64B | $2.41B | $2.33B |
| Income Before Tax Ratio | $0.63 | $0.39 | $0.63 | $0.23 |
| Income Tax Expense | $0.00 | $933.00M | $440.00M | $295.00M |
| Net Income | $1.88B | $5.64B | $1.97B | $1.94B |
| Net Income Ratio | $0.52 | $0.33 | $0.52 | $0.19 |
| EPS | $0.42 | $1.24 | $0.44 | $0.43 |
| Diluted EPS | $0.42 | $1.24 | $0.44 | $0.43 |
| Weighted Avg Shares Outstanding | $4.49B | $4.54B | $4.49B | $4.49B |
| Weighted Avg Shares Outstanding (Diluted) | $4.49B | $4.54B | $4.49B | $4.51B |
The company's financials show resilient growth, with revenue advancing from $9.99B in Q2 2024 to $3.65B in Q1 2025. Gross profit remained healthy with margins at 100% in Q1 2025 compared to 36% in Q2 2024. Operating income hit $2.30B last quarter, sustaining a consistent 63% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $2.30B. Net income dropped to $1.88B, while earnings per share reached $0.42. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan